Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, June 19, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Collaboration and Licensing Deals 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...
-
Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2025" report has been added to ResearchAndMarkets.com's offering.This report contains a...
-
Longeveron CEO Wa’el Hashad will present at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference.
-
Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Recombinant Cell Culture Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ...
-
TORONTO and HAIFA, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that on May 22, 2025,...
-
Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" has been added to ResearchAndMarkets.com's offering....
-
Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive...
-
Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Licensing Deals in Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Licensing Deals in Biotechnology provides a...
-
Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: Regenerative Medicine (2025)" has been added to ResearchAndMarkets.com's offering. The report offers insights into the...
-
Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations & Market Opportunity Insight 2025" has been added to ...